Big Pharma Bets on Crypto: $100M Litecoin Treasury Deal Shakes Market
Pharma just found its new growth hormone—and it’s not what you’d expect. A major pharmaceuticals firm just inked a deal to back a $100M Litecoin treasury, proving even traditional industries are chasing crypto’s high.
Why Litecoin? Faster transactions, lower fees—perfect for moving nine-figure sums without Wall Street’s usual tollbooths. The deal’s timing? Impeccable, as institutional crypto plays go from fringe to fundamental.
Cynics will call it a hedge against inflation (or desperation). Optimists see a blueprint for corporate treasuries in the digital age. Either way, the message is clear: when Big Pharma starts hoarding LTC, maybe it’s time to rethink what ‘blue-chip’ means.